Ethnopharmacological Relevance: Verbascum thapsus L. is a prized medicinal plant from the Kashmir Himalaya traditionally utilized to treat many ailments, yet its active metabolites against antimicrobial mechanisms remain unclear. Aim of the Study: This work envisages an integrated in-silico and in-vitro approach to mechanistically investigate broad-spectrum antimicrobial activity of carpachromene, a supradecorated phytochemical from V . thapsus . Materials and Methods: Carpachromene was isolated through cold extraction from V . thapsus , followed by silica gel column chromatography with an optimized polarity solvent system, yielding a whitish amorphous solid confirmed by XRD, FTIR, 1 H NMR and 13 C NMR spectroscopy. In-silico analyses encompassed molecular docking of carpachromene against key microbial drug targets like sterol 14-α demethylase (CYP51), Dihydropteroate synthase (DHPS), GyrB ATPase domain, and Penicillin-Binding Protein 1 (PBP-1) followed by 100 ns molecular dynamics simulations assessing RMSD, RMSF, dynamic cross-correlation matrix (DCCM), principal component analysis (PCA), radius of gyration (Rg), and solvent accessible surface area (SASA). In-vitro antimicrobial activity was assessed using the agar well-diffusion method against clinical isolates: bacterial pathogens ( Escherichia coli OP268610, Staphylococcus aureus OP268597, Salmonella enterica OP268585, Pseudomonas aeruginosa OP268614, Klebsiella pneumoniae OP268611, Bacillus cereus OP268602) and fungal pathogens ( Aspergillus niger MTCC183, A. fumigatus MTCC282, Candida albicans MTCC343), evaluating concentration-dependent inhibition zones relative to standard controls (ciprofloxacin for bacteria; fluconazole for fungi). Results: Docking studies revealed robust binding affinities for carpachromene, ranging from −9.3 to −10.5 kcal/mol across targets (CYP51: −10.5 kcal/mol; E. coli DHPS: −9.6 kcal/mol; S. aureus GyrB: −9.4 kcal/mol; PBP-1: −9.3 kcal/mol) driven by hydrogen bonding (e.g., with active-site residues like Asp 73, Thr 165, Gly 77 in GyrB ATPase) and other hydrophobic interactions. MD simulations affirmed complex stability (RMSD: 1.2–1.5 Å; RMSF: 0.69–1.07 Å), with persistent intermolecular contacts, and coordinated residue motions via DCCM/PCA. In-vitro results revealed potent, dose-dependent activity, yielding maximum inhibition zones of 21 mm against S. enterica (50 μg/mL) and 10 mm against C. albicans . Conclusion: The mechanistic insights from computational analysis corroborated with in-vitro observations, highlighting carpachromene as a promising multi-target antimicrobial scaffold. These findings support supradecoration strategies for advancing carpachromene toward novel drug development against antimicrobial resistance.